Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells.

[1]  H. Saito,et al.  Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  P. Dijke,et al.  Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells , 2001, Journal of cellular physiology.

[3]  Y. Taniyama,et al.  Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. , 2000, Circulation.

[4]  H. Koike,et al.  Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. , 1995, European journal of pharmacology.

[5]  T. Takano,et al.  Quantitative analysis of rat thyroglobulin messenger RNA in FRTL-5 cells by competitive polymerase chain reaction with human thyroglobulin messenger RNA. , 1997, Endocrine research.

[6]  W. Hsueh,et al.  Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. , 2000, Circulation.

[7]  J. Rodés,et al.  The role of vasoactive mediators in portal hypertension. , 1995, Seminars in gastrointestinal disease.

[8]  Y. Chrétien,et al.  Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver. , 1988, The Journal of pharmacology and experimental therapeutics.

[9]  I. Dixon,et al.  Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters. , 2000, Cardiovascular research.

[10]  I. Dixon,et al.  Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. , 1999, Journal of molecular and cellular cardiology.

[11]  H. Yoshiji,et al.  Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats , 2001, Hepatology.

[12]  V. Arroyo,et al.  Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis , 1980 .

[13]  C. Klein,et al.  Effect of losartan, an Angiotensin II receptor antagonist, on portal pressure in cirrhosis , 1999, Hepatology.

[14]  S. Kagami,et al.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. , 1994, The Journal of clinical investigation.

[15]  C. Chatziantoniou,et al.  Angiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway , 2000, Hypertension.

[16]  K. Tanikawa,et al.  Ito cell contraction in response to endothelin‐1 and substance P , 1993, Hepatology.

[17]  G. Gibbons,et al.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. , 1992, The Journal of clinical investigation.

[18]  T. Resink,et al.  Stimulation of autocrine platelet--derived growth factor AA-homodimer and transforming growth factor beta in vascular smooth muscle cells. , 1991, Biochemical and biophysical research communications.

[19]  M. Kendrick,et al.  High-throughput RT-PCR analysis of multiple transcripts using a microplate RNA isolation procedure. , 1997, BioTechniques.

[20]  J. Fallowfield,et al.  Interleukin‐10 expression and function in experimental murine liver inflammation and fibrosis , 1998, Hepatology.

[21]  W. Bennett,et al.  Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. , 1997, Kidney international.

[22]  Y. Matsuzawa,et al.  Effects of exogenous human heparin-binding epidermal growth factor-like growth factor on DNA synthesis of hepatocytes in normal mouse liver. , 1999, Biochemical and biophysical research communications.

[23]  Y. Furukawa,et al.  Apoptosis during HL‐60 cell differentiation is closely related to a G0/G1 cell cycle arrest , 1995, Journal of cellular physiology.

[24]  S. Milani,et al.  Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. , 1993, Gastroenterology.

[25]  H. Moses,et al.  Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[26]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[27]  F. Ramires,et al.  Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart , 1998 .

[28]  W. Border,et al.  Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? , 1997, Seminars in nephrology.

[29]  Y Ando,et al.  Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. , 2001, Gastroenterology.

[30]  Y. Zou,et al.  Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. , 1997, Circulation research.

[31]  R. Bataller,et al.  Angiotensin II induces contraction and proliferation of human hepatic stellate cells. , 2000, Gastroenterology.

[32]  T. Nakamura,et al.  Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. , 1984, Biochemical and biophysical research communications.

[33]  J. Stockand,et al.  Glomerular mesangial cells: electrophysiology and regulation of contraction. , 1998, Physiological reviews.

[34]  S. Friedman,et al.  Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice , 2002, Hepatology.

[35]  D. Rockey,et al.  Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance , 1996, Hepatology.

[36]  Takeshi Imamura,et al.  TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .

[37]  P. Angus,et al.  Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. , 2001, Journal of hepatology.

[38]  D. Purdie,et al.  Host genetic factors influence disease progression in chronic hepatitis C , 2000, Hepatology.

[39]  I. Dixon,et al.  Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. , 2000, American journal of physiology. Heart and circulatory physiology.

[40]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[41]  R. Ardaillou,et al.  Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. , 1992, The American journal of physiology.

[42]  Y. Matsuzawa,et al.  Alteration in growth regulation of hepatocytes in primary culture obtained from cirrhotic rat: Poor response to transforming growth factor‐β1 and interferons , 1994, Hepatology.